Cigna Group (CI)
(Delayed Data from NYSE)
$329.29 USD
+3.58 (1.10%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $329.29 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CI 329.29 +3.58(1.10%)
Will CI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CI
Cigna (CI) Q2 Earnings Top on Specialty Business Strength
Cigna (CI) Reports Q2 Earnings: What Key Metrics Have to Say
CI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cigna (CI) Q2 Earnings and Revenues Beat Estimates
Cigna (CI) is a Top-Ranked Growth Stock: Should You Buy?
Cigna (CI) is a Top-Ranked Growth Stock: Should You Buy?
Other News for CI
See Which Of The Latest 13F Filers Holds The Cigna Group
How Is The Market Feeling About Cigna?
The Cigna Group Foundation Announces Grants to 22 Nonprofits to Help Address the Youth Mental Health Crisis
Wall Street Analysts Are Bullish on Top Healthcare Picks
Cigna’s Q2 Performance: Solid Results but Cautious Outlook Keeps Hold Rating Intact